The IPO was way too early, and one of the few pillars of its business plan was the partnership. The fact that Moderna walked away means that has collapsed. In the future, IP could be another issue.
Recent MGX News
- Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/28/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:10:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:09:09 PM
- Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/11/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/27/2026 08:59:29 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 08:58:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 08:55:23 PM
- Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency • GlobeNewswire Inc. • 04/16/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:11:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 05:40:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:16:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:16:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 09:15:57 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/05/2026 09:20:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:09:43 PM
- Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/05/2026 09:05:00 PM
- Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference • GlobeNewswire Inc. • 02/23/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:27:39 PM
- Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook • GlobeNewswire Inc. • 01/12/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 06:56:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 06:51:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 06:49:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 06:38:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2025 12:34:10 AM
